Lung - Cancer
This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung cancer (NSCLC). While adjuvant osimertinib...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Timur Kyashif, a cardiac resident at Jena University Hospital in Jena, Germany, about the German Society for Thoracic, Cardiac,...
In this noteworthy interview, CTSNet Editor-in-Chief Joel Dunning speaks with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San Francisco,...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San...
This Society of Thoracic Surgeons Expert Consensus Documents provides updated, multidisciplinary guidance on the multimodal management of pleural mesothelioma (PM). The expert panel emphasizes that surgical resection should only be...
